269409-74-7

Usage

Uses

Used in Organic Chemistry Research:
3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid is used as a research compound for exploring its potential in specialized chemical reactions. Its unique structure, including the tetramethyl-1,3,2-dioxaborolan-2-yl group and the methyl group, makes it a candidate for creating various refined products in the field of organic chemistry.
Used in Chemical Synthesis:
In the chemical synthesis industry, 3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid is used as an intermediate or a building block in the synthesis of more complex molecules. Its structure allows for further reactions and modifications, contributing to the development of new chemical entities.
Used in Pharmaceutical Development:
Although not widely documented, 3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid may also be used in the pharmaceutical industry as a potential precursor or intermediate in the synthesis of drug molecules. Its unique structural features could be exploited to develop new therapeutic agents, pending further research and development.

Upstream product

• 7697-28-1 4-bromo-3-methylbenzoic acid 
• 73183-34-3 bis(pinacol)diborane 
• 52107-87-6 4-iodo-3-methylbenzoic acid 

Downstream Products

• 1253926-81-6 N,N,3-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide 
• 1258878-89-5 2-methyl-4'-(8-[(3-methylpyridin-2-yl)methyl]-2,4-dioxo-1,3,8-triazaispiro[4.5]dec-3-yl)biphenyl-4-carboxylic acid 
• 473596-87-1 4-methoxycarbonyl-2-methylbenzeneboronic acid pinacol ester 
• 911370-69-9 4-(8-(2,6-difluorophenyl)-2-{[2-(dimethylamino)ethyl]amino}-7-oxo-5,6,7,8-tetrahydropyrimido[4,5-d]pyrimidin-4-yl)-3-methylbenzoic acid 

Relevant academic research and scientific papers

SAR Exploration of Tight-Binding Inhibitors of Influenza Virus PA Endonuclease

Significant efforts have been reported on the development of influenza antivirals including inhibitors of the RNA-dependent RNA polymerase PA N-terminal (PAN) endonuclease. Based on recently identified, highly active metal-binding pharmacophore

Design, synthesis, and structure-activity relationships of aminopyridine N-oxides, a novel scaffold for the potent and selective inhibition of p38 mitogen activated protein kinase

A novel series of aminopyridine N-oxides were designed, synthesized, and tested for their ability to inhibit p38α MAP kinase. Some of these compounds showed a significant reduction in the LPS-induced TNFR production in human whole blood. Structure-activit

HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are Heteroaryl Compounds having the following structure: (I) wherein R1, R2, L, X, Y, Z, Q, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.

NOVEL COMPOUNDS

Novel substituted 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(1H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.

NOVEL COMPOUNDS

Novel substituted l,5,7-trisubstituted-354-dihydro-pyriinido[4,5-(flpyrimidin- 2-(2H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.